FDA Clears UCLA Heart Tissue Regeneration Drug AD-NP1 for Clinical Trials
October 07, 2025
October 07, 2025
LOS ANGELES, California, Oct. 7 -- The University of California issued the following news release:
* * *
FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials
Funded entirely by taxpayer dollars, this first-of-its-kind drug targets cellular metabolism to promote tissue repair of multiple organs
Key takeaways
* Internal organ tissues often don't heal after illness or injury and lose some function, such as th . . .
* * *
FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials
Funded entirely by taxpayer dollars, this first-of-its-kind drug targets cellular metabolism to promote tissue repair of multiple organs
Key takeaways
* Internal organ tissues often don't heal after illness or injury and lose some function, such as th . . .